FDA authorizes Pfizer's COVID-19 vaccine for ages 12 to 15
The U.S. Food and Drug Administration on Monday authorized the use of the Pfizer-BioNTech COVID-19 vaccine for adolescents age 12 to 15.
Pfizer has said clinical trials show its COVID-19 vaccine to be 100 percent effective in this age group. The vaccine already has been approved for people age 16 and up.
The approval sets the stage for many middle schoolers and young high school students to be vaccinated before the next school year. However, the Centers for Disease Control and Prevention must also approve the authorization before vaccinations for the age group can begin.
More stories from theweek.com
U.S. gas prices rise above $3 a gallon amid pipeline ransomware attack, inflation concerns
Ted Cruz walks out of gun violence hearing after failing to change the subject
An anti-vax conspiracy theory is apparently making anti-maskers consider masking up, social distancing
